Status:
COMPLETED
Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients
Lead Sponsor:
Novartis
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This extension study is to assess the long-term safety of EC-MPS
Eligibility Criteria
Inclusion
- Inclusion / Exclusion Criteria - All patients who completed study CERL080A2405-IN01 and who are willing to continue treatment with Enteric-Coated Mycophenolate Sodium.
- Other protocol-defined inclusion / exclusion criteria may apply
- \-
Exclusion
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00239070
Start Date
April 1 2003
End Date
May 1 2006
Last Update
January 31 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.